What is GNPX's current stock price?

GNPX (Genprex, Inc.) is currently trading at $0.82 with a market cap of $1.3M.

What sector is Genprex, Inc. in?

Genprex, Inc. (GNPX) operates in the Healthcare sector, specifically in the Biotechnology industry.

InvestLog

GNPX Genprex, Inc.

Healthcare

$0.82+0.75%ClosedMarket Cap: $1.3M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

0.34

P/S

0.00

EV/EBITDA

1.04

DCF Value

$7.64

FCF Yield

-1066.4%

Div Yield

0.0%

Margins & Returns

Gross Margin

0.0%

Operating Margin

0.0%

Net Margin

0.0%

ROE

-247.3%

ROA

-82.4%

ROIC

-94.6%

Financials

View All

Period	Revenue	Net Income	EPS
Q1 null	$0.00	$-4.5M	$—
Q4 null	$0.00	$-3.8M	$—
FY null	$0.00	$-16.2M	$—
Q3 null	$0.00	$-3.8M	$—

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$—

Target (Median)

$—

Target Range

$— - $—

0 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell

Trading Activity

Insider Trades

View All

LONGNECKER BRENT Mdirector

SellWed Apr 15

LONGNECKER BRENT Mdirector

SellWed Apr 15

Confer Ryan M.director, officer: President, CEO and CFO

SellFri Feb 27

Berger Mark Stanleyofficer: Chief Medical Officer

SellFri Feb 27

Wilson William R Jr.director

SellTue Dec 23

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

Exchange

—

Beta

-0.93

Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas.

Peers

GRI

INM

JAGX

LIMN

TOVX